Traditional Chinese medicine injection for pandemic influenza A(H1N1) cases of critical condition: an open loading ambispective cohort study

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-10000815

Enrollment

Unknown

Registered

2010-02-04

Start date

2010-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pandemic influenza A(H1N1) cases of critical condition

Interventions

study group:traditional Chinese medicine injection combined with routine western medicine treatment: application of Reduling Injection, Xiyanping Injection, Danshen Injection,Shenmai Injection and She

control group:routine western medicine treatment

Eligibility

Sex/Gender

All

Age

6 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Meet with the diagnostic standard of pandemic influenza A(H1N1) cases of critical condition including suspected cases, clinical diagnosis cases, confirmed cases, and belonging to depletion syndrome; (2)age: 6 and over; (3) patients or their guardians agree to participate in randomized controlled trials and signed the informed consent

Exclusion criteria

Exclusion criteria: patients with allergic constitution

Design outcomes

Primary

Measure	Time frame
incidence of complications;mortalit;	—

Secondary

Measure	Time frame
direct medical cost;the days and parameter variation of respirator uti;length of stay(days);fever clearance time;safety outcomes;symptoms;clearance time and negative rate of pandemic influ;APACHE II Scores, Marshall Score;APACHE II Scores, Marshall Scores;	—

Countries

China

Contacts

Public ContactWang Zhong

zhonw@vip.sina.com+86 010 64014411-3308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026